Pamela Coxson, PhD


Pamela Coxson, PhD is a mathematician with the Division of General and Internal Medicine and member of the CVP Cardiovascular Disease Modelling Group. She is responsible for design and maintenance of the CHD Policy Model, implementation of analyses using the Model, and interpretation of Model data. Current projects include adaptation of the Model to assess the CHD burden and benefits of treatment in vulnerable populations. Dr. Coxson received her Ph.D. in mathematics from the University of Southern California.

  1. Konfino J, Salgado MV, Penko J, Coxson P, Fernández A, Pichon-Riviere A, Bibbins-Domingo K, Mejía R. Impacto sanitario de la prohibición total de publicidades de tabaco en argentina. "It's not the doctor - it's me." How self-blame obscures language and other structural barriers to diabetes care mong low-income Latinos with limited English Proficiency. 2022. PMID: 35440241

  2. Kazi DS, Wei PC, Penko J, Bellows BK, Coxson P, Bryant KB, Fontil V, Blyler CA, Lyles C, Lynch K, Ebinger J, Zhang Y, Tajeu GS, Boylan R, Pletcher MJ, Rader F, Moran AE, Bibbins-Domingo K. Scaling Up Pharmacist-Led Blood Pressure Control Programs in Black Barbershops: Projected Population Health Impact and Value. Circulation 2021. PMID: 34125566

  3. Bryant KB, Moran AE, Kazi DS, Zhang Y, Penko J, Ruiz-Negrón N, Coxson P, Blyler CA, Lynch K, Cohen LP, Tajeu GS, Fontil V, Moy NB, Ebinger JE, Rader F, Bibbins-Domingo K, Bellows BK. Cost-effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops. Circulation 2021. PMID: 33855861

  4. Hamad R, Penko J, Kazi DS, Coxson P, Guzman D, Wei PC, Mason A, Wang EA, Goldman L, Fiscella K, Bibbins-Domingo K. Association of Low Socioeconomic Status With Premature Coronary Heart Disease in US Adults. JAMA cardiology 2020. PMID: 32459344

  5. Salgado MV, Penko J, Fernandez A, Konfino J, Coxson PG, Bibbins-Domingo K, Mejia R. Projected impact of a reduction in sugar-sweetened beverage consumption on diabetes and cardiovascular disease in Argentina: A modeling study. PLoS medicine 2020. PMID: 32722677

  6. Medina C, Coxson P, Penko J, Janssen I, Bautista-Arredondo S, Barquera S, Bibbins-Domingo K. Cardiovascular and diabetes burden attributable to physical inactivity in Mexico. Cardiovascular diabetology 2020. PMID: 32600339

  7. Williams BA, Li A, Ahalt C, Coxson P, Kahn JG, Bibbins-Domingo K. The Cardiovascular Health Burdens of Solitary Confinement. Journal of general internal medicine 2019. PMID: 31228050

  8. Kazi DS, Penko J, Coxson PG, Guzman D, Wei PC, Bibbins-Domingo K. Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial. Annals of internal medicine 2019. PMID: 30597485

  9. Salgado MV, Coxson P, Konfino J, Penko J, Irazola VE, Gutiérrez L, Fernández A, Mejía R. Update of the cardiovascular disease policy model to predict cardiovascular events in Argentina. Medicina 2019. PMID: 31829945

  10. Kazi DS, Penko J, Ollendorf DA, Coxson PG, Bibbins-Domingo K. Effect of Money-Back Guarantees on the Cost-Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors. Annals of internal medicine 2018. PMID: 29610832

  11. Huang C, Moran AE, Coxson PG, Yang X, Liu F, Cao J, Chen K, Wang M, He J, Goldman L, Zhao D, Kinney PL, Gu D. Potential Cardiovascular and Total Mortality Benefits of Air Pollution Control in Urban China. Volume 136 of Issue 17. Circulation 2017. PMID: 28882886

  12. Kazi DS, Penko J, Coxson PG, Moran AE, Ollendorf DA, Tice JA, Bibbins-Domingo K. Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial. JAMA 2017. PMID: 28829863

  13. Heller DJ, Coxson PG, Penko J, Pletcher MJ, Goldman L, Odden MC, Kazi DS, Bibbins-Domingo K. Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke. Circulation 2017. PMID: 28687710

  14. Konfino J, Fernandez A, Penko J, Mason A, Martinez E, Coxson P, Heller D, Moran A, Bibbins-Domingo K, Pérez-Stable EJ, Mejía R. Comparing Strategies for Lipid Lowering in Argentina: An Analysis from the CVD Policy Model-Argentina. Journal of general internal medicine 2016. PMID: 27853916

  15. Sánchez-Romero LM, Penko J, Coxson PG, Fernández A, Mason A, Moran AE, Ávila-Burgos L, Odden M, Barquera S, Bibbins-Domingo K. Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study. PLoS medicine 2016. PMID: 27802278

  16. Kazi DS, Moran AE, Coxson PG, Penko J, Ollendorf DA, Pearson SD, Tice JA, Guzman D, Bibbins-Domingo K. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease. JAMA 2016. PMID: 27533159

  17. Moise N, Huang C, Rodgers A, Kohli-Lynch CN, Tzong KY, Coxson PG, Bibbins-Domingo K, Goldman L, Moran AE. Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model. Hypertension (Dallas, Tex. : 1979) 2016. PMID: 27181996

  18. Vasudeva E, Moise N, Huang C, Mason A, Penko J, Goldman L, Coxson PG, Bibbins-Domingo K, Moran AE. Comparative Cost-Effectiveness of Hypertension Treatment in Non-Hispanic Blacks and Whites According to 2014 Guidelines: A Modeling Study. American journal of hypertension 2016. PMID: 27172970

  19. Odden MC, Moran AE, Coxson PG, Peralta CA, Goldman L, Bibbins-Domingo K. Gait Speed as a Guide for Blood Pressure Targets in Older Adults: A Modeling Study. Journal of the American Geriatrics Society 2016. PMID: 27225357

  20. Wang M, Moran AE, Liu J, Coxson PG, Penko J, Goldman L, Bibbins-Domingo K, Zhao D. Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling Study. PloS one 2016. PMID: 26840409

  21. Gu D, He J, Coxson PG, Rasmussen PW, Huang C, Thanataveerat A, Tzong KY, Xiong J, Wang M, Zhao D, Goldman L, Moran AE. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study. Volume 12 of Issue 8. PLoS medicine 2015. PMID: 26241895

  22. Odden MC, Pletcher MJ, Coxson PG, Thekkethala D, Guzman D, Heller D, Goldman L, Bibbins-Domingo K. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States. Annals of internal medicine 2015. PMID: 25894023

  23. Fontil V, Bibbins-Domingo K, Kazi DS, Sidney S, Coxson PG, Khanna R, Victor RG, Pletcher MJ. Simulating Strategies for Improving Control of Hypertension Among Patients with Usual Source of Care in the United States: The Blood Pressure Control Model. Journal of general internal medicine 2015. PMID: 25749880

  24. Moran AE, Odden MC, Thanataveerat A, Tzong KY, Rasmussen PW, Guzman D, Williams L, Bibbins-Domingo K, Coxson PG, Goldman L. Cost-effectiveness of hypertension therapy according to 2014 guidelines. The New England journal of medicine 2015. PMID: 25629742

  25. Wang M, Moran AE, Liu J, Coxson PG, Heidenreich PA, Gu D, He J, Goldman L, Zhao D. Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China. Volume 7 of Issue 1. Circulation. Cardiovascular quality and outcomes 2014. PMID: 24425706

  26. Mekonnen TA, Odden MC, Coxson PG, Guzman D, Lightwood J, Wang YC, Bibbins-Domingo K. Health benefits of reducing sugar-sweetened beverage intake in high risk populations of California: results from the cardiovascular disease (CVD) policy model. PloS one 2013. PMID: 24349119

  27. Konfino J, Mekonnen TA, Coxson PG, Ferrante D, Bibbins-Domingo K. Projected impact of a sodium consumption reduction initiative in Argentina: an analysis from the CVD policy model--Argentina. PloS one 2013. PMID: 24040085

  28. Coxson PG, Bibbins-Domingo K, Cook NR, Joffres M, Schmidt SM. Response to mortality benefits from U.S. population-wide reduction in sodium consumption: projections from 3 modeling approaches. Hypertension (Dallas, Tex. : 1979) 2013. PMID: 23819150

  29. Coxson PG, Cook NR, Joffres M, Hong Y, Orenstein D, Schmidt SM, Bibbins-Domingo K. Mortality benefits from US population-wide reduction in sodium consumption: projections from 3 modeling approaches. Hypertension (Dallas, Tex. : 1979) 2013. PMID: 23399718

  30. Konfino J, Ferrante D, Mejia R, Coxson P, Moran A, Goldman L, Pérez-Stable EJ. Impact on cardiovascular disease events of the implementation of Argentina's national tobacco control law. Volume 23 of Issue 2. Tobacco control 2012. PMID: 23092886

  31. Ferrante D, Konfino J, Mejía R, Coxson P, Moran A, Goldman L, Pérez-Stable EJ. [The cost-utility ratio of reducing salt intake and its impact on the incidence of cardiovascular disease in Argentina]. Volume 32 of Issue 4. Revista panamericana de salud publica = Pan American journal of public health 2012. PMID: 23299288

  32. Chan F, Adamo S, Coxson P, Goldman L, Gu D, Zhao D, Chen CS, He J, Mara V, Moran A. Projected impact of urbanization on cardiovascular disease in China. Volume 57 of Issue 5. International journal of public health 2012. PMID: 22918518

  33. Wang YC, Coxson P, Shen YM, Goldman L, Bibbins-Domingo K. A penny-per-ounce tax on sugar-sweetened beverages would cut health and cost burdens of diabetes. Health affairs (Project Hope) 2012. PMID: 22232111

  34. Galper BZ, Moran A, Coxson PG, Pletcher MJ, Heidenreich P, Lazar LD, Rodondi N, Wang YC, Goldman L. Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysis. Volume 125 of Issue 2. Circulation 2011. PMID: 22144567

  35. Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K. The impact of the aging population on coronary heart disease in the United States. The American journal of medicine 2011. PMID: 21722862

  36. Lazar LD, Pletcher MJ, Coxson PG, Bibbins-Domingo K, Goldman L. Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era. Circulation 2011. PMID: 21709063

  37. Moran A, Degennaro V, Ferrante D, Coxson PG, Palmas W, Mejia R, Perez-Stable EJ, Goldman L. Coronary heart disease and stroke attributable to major risk factors is similar in Argentina and the United States: the Coronary Heart Disease Policy Model. Volume 150 of Issue 3. International journal of cardiology 2011. PMID: 21550675

  38. Victor RG, Ravenell JE, Freeman A, Leonard D, Bhat DG, Shafiq M, Knowles P, Storm JS, Adhikari E, Bibbins-Domingo K, Coxson PG, Pletcher MJ, Hannan P, Haley RW. Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Archives of internal medicine 2010. PMID: 20975012

  39. Pletcher MJ, Coxson PG. Does age modify effectiveness of statin therapy in coronary artery disease? Volume 152 of Issue 12. Annals of internal medicine 2010. PMID: 20547915

  40. Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, Liu J, Cheng J, Bibbins-Domingo K, Shen YM, He J, Goldman L. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circulation. Cardiovascular quality and outcomes 2010. PMID: 20442213

  41. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. The New England journal of medicine 2010. PMID: 20089957

  42. Lightwood J, Bibbins-Domingo K, Coxson P, Wang YC, Williams L, Goldman L. Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model. American journal of public health 2009. PMID: 19833999

  43. Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rodondi N, Coxson P, Lightwood J, Williams L, Goldman L. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Annals of internal medicine 2009. PMID: 19221376

  44. Lightwood JM, Coxson PG, Bibbins-Domingo K, Williams LW, Goldman L. Coronary heart disease attributable to passive smoking: CHD Policy Model. American journal of preventive medicine 2009. PMID: 19095162

  45. Moran A, Zhao D, Gu D, Coxson P, Chen CS, Cheng J, Liu J, He J, Goldman L. The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China. Volume 8. BMC public health 2008. PMID: 19036167

  46. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease. The New England journal of medicine 2007. PMID: 18057339